Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor

Chris Haigh(Wansbeck General Hospital), R. Dimaline(University of Liverpool), Chris M. Kirton(University of Liverpool), Andrea Varró(University of Liverpool), Stephen E. Attwood(Durham University), David G. Thompson, Janusz Jankowski(University College London), D. Mark Pritchard(University of Liverpool)

Gastroenterology

February 28, 2003

10.1053/gast.2003.50091

Cited by 151

Related Papers

Esophageal eosinophilia with dysphagia

|Digestive Diseases and Sciences|1993|889

A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop1 1Members of the workshop composed a group of international experts in BE from gastroenterology, surgery, pathology, molecular biology, outcomes, and epidemiology. Conference chairman: Prateek Sharma; conference moderator: Kenneth McQuaid; group leaders: John Dent, M. Brian Fennerty, Richard Sampliner, Stuart Spechler; participants: Alan Cameron, Douglas Corley, Gary Falk, John Goldblum, John Hunter, Janusz Jankowski, Lars Lundell, Brian Reid, Nicholas Shaheen, Amnon Sonnenberg, Kenneth Wang, and Wilfred Weinstein.

|Gastroenterology|2004|526

Estimates of benefits and harms of prophylactic use of aspirin in the general population

|Annals of Oncology|2014|388

Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process

|Gastroenterology|2012|378

Contribution of central sensitisation to the development of noncardiac chest pain

|The Lancet|2000|348